Advanced Code injection
0
Skip to Content
OBIO
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
OBIO
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
Folder: About
Back
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
Folder: Areas of Focus
Back
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
Folder: Events
Back
All Events
OBIO Investment Summit
Folder: News
Back
News & Press Releases
Tariff Relief Resources
Folder: Membership
Back
Membership
Member Log in
Job Board
Theralase Partners with SAFC in Manufacture of Anti-Cancer Drugs
Ontario Industry Updates obio 10/11/14 Ontario Industry Updates obio 10/11/14

Theralase Partners with SAFC in Manufacture of Anti-Cancer Drugs

Read More
Ontario Industry Updates obio 10/5/14 Ontario Industry Updates obio 10/5/14

Proteocyte Diagnostics Highest Ranked Life Sciences Company in NACO’s Most Promising Canadian Startup of the Year Competition

Read More
Ontario Industry Updates obio 10/5/14 Ontario Industry Updates obio 10/5/14

Rna Diagnostics Awarded Patent for Test that Guides Cancer Chemotherapy

Read More
Ontario Industry Updates obio 9/29/14 Ontario Industry Updates obio 9/29/14

AvidBiologics Closes New Financing Round

Read More
Ontario Industry Updates obio 9/17/14 Ontario Industry Updates obio 9/17/14

AbCelex Technologies Inc. Secures an Additional $1 Million in Series A Financing

Read More
Ontario Industry Updates obio 9/13/14 Ontario Industry Updates obio 9/13/14

Entrepreneur redevelops one of life’s scariest tests

Read More
Articles and Reports obio 8/1/14 Articles and Reports obio 8/1/14

OBIO Celebrates Five Years Advancing Ontario's Human Health Technology and Bioscience Ecosystem

Read More
Articles and Reports obio 8/1/14 Articles and Reports obio 8/1/14

BLG LifeSigns Article: Ontario Bioscience Innovation Organization - OBIO

Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14

Armour Therapeutics discovers synergies between prostate cancer treatment and conventional chemotherapy to treat aggressive tumours

Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14

AbCelex Technologies Secures Two Million in Series A Financing

Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14

Kevin Egan Joins Sernova as Chair Business Advisory Board

Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14

Interface Biologics Appoints Dion Madsen to Board of Directors

Read More
Ontario Industry Updates obio 5/8/14 Ontario Industry Updates obio 5/8/14

Sernova Announces Appointment of Nick Borrelly to Corporate Development Role

Read More
Ontario Industry Updates obio 4/28/14 Ontario Industry Updates obio 4/28/14

Sernova’s Cell Pouch™ Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility

Read More
Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14

Spectral Updates Status Of EUPHRATES Trial

Read More
Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14

Profound Medical Announces Closing of Enrollment Into TULSA Clinical Trial for Treatment of Localized Prostate Cancer

Read More
Ontario Industry Updates obio 4/9/14 Ontario Industry Updates obio 4/9/14

Critical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer

Read More
Ontario Industry Updates obio 3/26/14 Ontario Industry Updates obio 3/26/14

Dalton Pharma Services Announces Completion of a Major Expansion in Aseptic Filling Capabilities

Read More
Ontario Industry Updates obio 2/28/14 Ontario Industry Updates obio 2/28/14

Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law

Read More
Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14

Debiopharm Group™ to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics

Read More
Newer Posts
Older Posts
Become an OBIO® Member Today!

Contact us:

OBIO®
101 College St., Suite HL50

Toronto, ON M5G 1L7

OBIO © 2026

(416) 848 6839
info@obio.ca

Media Kit

NEWSlETTER Sign UP

Terms & Conditions